Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announced on 29 March 2023 the profit distribution proposal for 2022 as follows: Cash dividend (tax included) of CNY 8.00000000 per 10 shares.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Equities
301096
CNE1000056N5
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.54 CNY | +0.70% | -2.55% | -2.40% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.40% | 949M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+43.74% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- 301096 Stock
- News Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
- Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022